Description
Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor with IC50 values of 0.37 nM (Abl), 1.1 nM (PDGFRα), 1.5 nM (VEGFR2), 2.2 nM (FGFR1), and 5.4 nM (Src).
Molecular Formula
C29H27F3N6O
Smiles
C(#CC1=CC(C(NC2=CC(C(F)(F)F)=C(CN3CCN(C)CC3)C=C2)=O)=CC=C1C)C=4N5C(=NC4)C=CC=N5
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
Ethanol: 26.6 mg/mL (50 mM)DMSO: 16.67 mg/mL (31.3 mM)10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5.33 mg/mL (10.01 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.